# CRISAL Study:Cancer Risk In Secreting Adrenal Lesions

> **NCT06520111** · — · RECRUITING · sponsor: **University of Roma La Sapienza** · enrollment: 300 (estimated)

## Conditions studied

- Adrenal Tumor
- Adrenal Incidentaloma
- Surgery

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06520111
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-27
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-11-10
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06520111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06520111, "CRISAL Study:Cancer Risk In Secreting Adrenal Lesions". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06520111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*